6BC-15724-60554
2 vaccinations
7 coded responses
30 check-ins
7 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 027 / MA
- Registered
- 2021-03-08
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-08
Registered in v-safe
-
2021-03-08
Dose 1 — Janssen/Johnson & Johnson
- 2021-03-08
-
2021-03-09
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-10
- 2021-03-11
- 2021-03-12
- 2021-03-13
- 2021-03-14
- 2021-03-15
- 2021-03-22
- 2021-03-29
- 2021-04-05
- 2021-04-12
- 2021-04-19
- 2021-06-07
- 2021-09-06
-
2021-12-23
Dose 2 — Moderna
- 2021-12-23
-
2021-12-24
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-12-25
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Muscle or body achesAdult check-in
-
2021-12-26
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Muscle or body achesAdult check-in
-
2021-12-27
Survey response — days 1–6 daily, dose 2MedDRA: Oropharyngeal pain — Feeling: Fair · Muscle or body aches, Fatigue or tirednessFree text: Sore throatMedDRA releases: 2024-11 · check-in free text available
-
2021-12-28
Survey response — days 1–6 daily, dose 2MedDRA: Respiratory tract congestion, Rhinorrhoea — Feeling: GoodFree text: Runny nose, congestionMedDRA releases: 2024-11 · check-in free text available
-
2021-12-30
Survey response — day 7, dose 2MedDRA: Respiratory tract congestion, Rhinorrhoea — Feeling: GoodFree text: Runny nose congestionMedDRA releases: 2024-11 · check-in free text available
-
2022-01-06
Survey response — day 14, dose 2MedDRA: Ovarian cyst ruptured — Feeling: Good · Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Ruptured Ovarian CystMedDRA releases: 2024-11 · check-in free text available
-
2022-01-06
Report sent to call center — day 14, dose 2Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · 1 call case(s)
- 2022-01-10
- 2022-01-13
- 2022-01-20
- 2022-01-27
-
2022-02-03
Survey response — day 42, dose 2MedDRA: Ovarian cyst ruptured — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: 2nd ovarian cyst ruptureMedDRA releases: 2024-11 · check-in free text available
-
2022-03-24
Survey response — 3 months, dose 2MedDRA: Sinus congestion — Feeling: FairFree text: Sinus congestionMedDRA releases: 2024-11 · check-in free text available
-
2022-06-23
Survey response — 6 months, dose 2MedDRA: Abortion spontaneous — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: MiscarriageMedDRA releases: 2024-11 · check-in free text available
-
2022-06-23
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · 1 call case(s)
-
2022-06-24
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-06-24
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-12-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-08 | Janssen/Johnson & Johnson | |
| 2 | 2021-12-23 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-01-06 | Successful 2022-06-24 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
| 2022-06-23 | Successful 2022-06-24 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 10 — days 1–6 daily, dose 2
Systemic reaction (other): Sore throat
Systemic reaction (other): Runny nose, congestion
Release 10 — day 7, dose 2
Systemic reaction (other): Runny nose congestion
Release 10 — day 14, dose 2
Symptoms: Ruptured Ovarian Cyst
Release 11 — day 42, dose 2
Symptoms: 2nd ovarian cyst rupture
Release 11 — 3 months, dose 2
Symptoms: Sinus congestion
Release 12 — 6 months, dose 2
Symptoms: Miscarriage
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | · | · | ✓ |
| SD | Ovarian cyst ruptured | · | · | ✓ |
| SD | Sinus congestion | · | · | ✓ |
| SRO | Oropharyngeal pain | · | · | ✓ |
| SRO | Respiratory tract congestion | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release